Loading data
AURANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 90.3 m USD | 73.3 m USD | 65.23 m USD | 42.24 m USD | 25.16 m USD |
| Operating profit | -112.79 m USD | -96.12 m USD | -84.99 m USD | -60.3 m USD | -35.25 m USD |
| Profit before tax | -106.08 m USD | -86.81 m USD | -76.27 m USD | -58.76 m USD | — |
| Income tax expense | 108 k USD | 100 k USD | 100 k USD | 0 USD | — |
| Net income (reported basis) | -106.2 m USD | -86.92 m USD | -76.41 m USD | -58.76 m USD | -35.25 m USD |
| Basic earnings per share | -1.76 USD/share | -1.75 USD/share | -1.93 USD/share | -1.96 USD/share | -8.95 USD/share |
| Diluted earnings per share | -1.76 USD/share | -1.75 USD/share | -1.93 USD/share | -1.96 USD/share | -8.95 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.